0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Personalized Therapy Biosimulation Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-25P14490
Home | Market Reports | Health| Health Conditions
Global Personalized Therapy Biosimulation Platform Market Research Report 2023
BUY CHAPTERS

Personalized Therapy Biosimulation Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25P14490
Report
November 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Personalized Therapy Biosimulation Platform - Market Size

The global market for Personalized Therapy Biosimulation Platform was estimated to be worth US$ 1394.3 million in 2023 and is forecast to a readjusted size of US$ 3619.6 million by 2030 with a CAGR of 14.6% during the forecast period 2024-2030

Personalized Therapy Biosimulation Platform - Market

Personalized Therapy Biosimulation Platform - Market

Personalized Therapy Biosimulation refers to biosimulating a patient's unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient's Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.
Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Personalized Therapy Biosimulation Platform, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Personalized Therapy Biosimulation Platform by region & country, by Type, and by Application.
The Personalized Therapy Biosimulation Platform market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Therapy Biosimulation Platform.
Market Segmentation

Scope of Personalized Therapy Biosimulation Platform - Market Report

Report Metric Details
Report Name Personalized Therapy Biosimulation Platform - Market
Forecasted market size in 2030 US$ 3619.6 million
CAGR 14.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Pharmacokinetic
  • Pharmacoeconomics
Segment by Application
  • Pharmaceutical and Biotech Companies
  • Research Institutions
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic, Shanghai Lide
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Personalized Therapy Biosimulation Platform manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Personalized Therapy Biosimulation Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Personalized Therapy Biosimulation Platform in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Personalized Therapy Biosimulation Platform - Market size in 2030?

Ans: The Personalized Therapy Biosimulation Platform - Market size in 2030 will be US$ 3619.6 million.

Who are the main players in the Personalized Therapy Biosimulation Platform - Market report?

Ans: The main players in the Personalized Therapy Biosimulation Platform - Market are Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic, Shanghai Lide

What are the Application segmentation covered in the Personalized Therapy Biosimulation Platform - Market report?

Ans: The Applications covered in the Personalized Therapy Biosimulation Platform - Market report are Pharmaceutical and Biotech Companies, Research Institutions, Hospital, Others

What are the Type segmentation covered in the Personalized Therapy Biosimulation Platform - Market report?

Ans: The Types covered in the Personalized Therapy Biosimulation Platform - Market report are Pharmacokinetic, Pharmacoeconomics

1 Market Overview
1.1 Personalized Therapy Biosimulation Platform Product Introduction
1.2 Global Personalized Therapy Biosimulation Platform Market Size Forecast
1.3 Personalized Therapy Biosimulation Platform Market Trends & Drivers
1.3.1 Personalized Therapy Biosimulation Platform Industry Trends
1.3.2 Personalized Therapy Biosimulation Platform Market Drivers & Opportunity
1.3.3 Personalized Therapy Biosimulation Platform Market Challenges
1.3.4 Personalized Therapy Biosimulation Platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Personalized Therapy Biosimulation Platform Players Revenue Ranking (2023)
2.2 Global Personalized Therapy Biosimulation Platform Revenue by Company (2019-2024)
2.3 Key Companies Personalized Therapy Biosimulation Platform Manufacturing Base Distribution and Headquarters
2.4 Key Companies Personalized Therapy Biosimulation Platform Product Offered
2.5 Key Companies Time to Begin Mass Production of Personalized Therapy Biosimulation Platform
2.6 Personalized Therapy Biosimulation Platform Market Competitive Analysis
2.6.1 Personalized Therapy Biosimulation Platform Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Personalized Therapy Biosimulation Platform Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Therapy Biosimulation Platform as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pharmacokinetic
3.1.2 Pharmacoeconomics
3.2 Global Personalized Therapy Biosimulation Platform Sales Value by Type
3.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Personalized Therapy Biosimulation Platform Sales Value, by Type (2019-2030)
3.2.3 Global Personalized Therapy Biosimulation Platform Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotech Companies
4.1.2 Research Institutions
4.1.3 Hospital
4.1.4 Others
4.2 Global Personalized Therapy Biosimulation Platform Sales Value by Application
4.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Personalized Therapy Biosimulation Platform Sales Value, by Application (2019-2030)
4.2.3 Global Personalized Therapy Biosimulation Platform Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Personalized Therapy Biosimulation Platform Sales Value by Region
5.1.1 Global Personalized Therapy Biosimulation Platform Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Personalized Therapy Biosimulation Platform Sales Value by Region (2019-2024)
5.1.3 Global Personalized Therapy Biosimulation Platform Sales Value by Region (2025-2030)
5.1.4 Global Personalized Therapy Biosimulation Platform Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
5.2.2 North America Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
5.3.2 Europe Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
5.4.2 Asia Pacific Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
5.5.2 South America Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
5.6.2 Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value
6.3 United States
6.3.1 United States Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.3.2 United States Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.4.2 Europe Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.5.2 China Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.5.3 China Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.6.2 Japan Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.7.2 South Korea Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.8.2 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Personalized Therapy Biosimulation Platform Sales Value, 2019-2030
6.9.2 India Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
6.9.3 India Personalized Therapy Biosimulation Platform Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cellworks Group
7.1.1 Cellworks Group Profile
7.1.2 Cellworks Group Main Business
7.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.1.4 Cellworks Group Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.1.5 Cellworks Group Recent Developments
7.2 Certara
7.2.1 Certara Profile
7.2.2 Certara Main Business
7.2.3 Certara Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.2.4 Certara Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.2.5 Certara Recent Developments
7.3 Simulation Plus
7.3.1 Simulation Plus Profile
7.3.2 Simulation Plus Main Business
7.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.3.4 Simulation Plus Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.3.5 Schrodinger Recent Developments
7.4 Schrodinger
7.4.1 Schrodinger Profile
7.4.2 Schrodinger Main Business
7.4.3 Schrodinger Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.4.4 Schrodinger Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.4.5 Schrodinger Recent Developments
7.5 In Silico Biosciences
7.5.1 In Silico Biosciences Profile
7.5.2 In Silico Biosciences Main Business
7.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.5.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.5.5 In Silico Biosciences Recent Developments
7.6 Genedata
7.6.1 Genedata Profile
7.6.2 Genedata Main Business
7.6.3 Genedata Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.6.4 Genedata Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.6.5 Genedata Recent Developments
7.7 Physiomics
7.7.1 Physiomics Profile
7.7.2 Physiomics Main Business
7.7.3 Physiomics Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.7.4 Physiomics Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.7.5 Physiomics Recent Developments
7.8 Insilico Biotechology
7.8.1 Insilico Biotechology Profile
7.8.2 Insilico Biotechology Main Business
7.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.8.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.8.5 Insilico Biotechology Recent Developments
7.9 Chemical Computing Group ULC(CCG)
7.9.1 Chemical Computing Group ULC(CCG) Profile
7.9.2 Chemical Computing Group ULC(CCG) Main Business
7.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.9.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.9.5 Chemical Computing Group ULC(CCG) Recent Developments
7.10 Evidera
7.10.1 Evidera Profile
7.10.2 Evidera Main Business
7.10.3 Evidera Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.10.4 Evidera Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.10.5 Evidera Recent Developments
7.11 AnyLogic
7.11.1 AnyLogic Profile
7.11.2 AnyLogic Main Business
7.11.3 AnyLogic Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.11.4 AnyLogic Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.11.5 AnyLogic Recent Developments
7.12 Shanghai Lide
7.12.1 Shanghai Lide Profile
7.12.2 Shanghai Lide Main Business
7.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Products, Services and Solutions
7.12.4 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue (US$ Million) & (2019-2024)
7.12.5 Shanghai Lide Recent Developments
8 Industry Chain Analysis
8.1 Personalized Therapy Biosimulation Platform Industrial Chain
8.2 Personalized Therapy Biosimulation Platform Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Personalized Therapy Biosimulation Platform Sales Model
8.5.2 Sales Channel
8.5.3 Personalized Therapy Biosimulation Platform Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Personalized Therapy Biosimulation Platform Market Trends
    Table 2. Personalized Therapy Biosimulation Platform Market Drivers & Opportunity
    Table 3. Personalized Therapy Biosimulation Platform Market Challenges
    Table 4. Personalized Therapy Biosimulation Platform Market Restraints
    Table 5. Global Personalized Therapy Biosimulation Platform Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Personalized Therapy Biosimulation Platform Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Personalized Therapy Biosimulation Platform Product Type
    Table 9. Key Companies Time to Begin Mass Production of Personalized Therapy Biosimulation Platform
    Table 10. Global Personalized Therapy Biosimulation Platform Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Therapy Biosimulation Platform as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Personalized Therapy Biosimulation Platform Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Personalized Therapy Biosimulation Platform Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Personalized Therapy Biosimulation Platform Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Personalized Therapy Biosimulation Platform Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Personalized Therapy Biosimulation Platform Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Personalized Therapy Biosimulation Platform Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Personalized Therapy Biosimulation Platform Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2019-2024) & (%)
    Table 27. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value, (2025-2030) & (US$ Million)
    Table 31. Cellworks Group Basic Information List
    Table 32. Cellworks Group Description and Business Overview
    Table 33. Cellworks Group Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Cellworks Group (2019-2024)
    Table 35. Cellworks Group Recent Developments
    Table 36. Certara Basic Information List
    Table 37. Certara Description and Business Overview
    Table 38. Certara Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Certara (2019-2024)
    Table 40. Certara Recent Developments
    Table 41. Simulation Plus Basic Information List
    Table 42. Simulation Plus Description and Business Overview
    Table 43. Simulation Plus Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Simulation Plus (2019-2024)
    Table 45. Simulation Plus Recent Developments
    Table 46. Schrodinger Basic Information List
    Table 47. Schrodinger Description and Business Overview
    Table 48. Schrodinger Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Schrodinger (2019-2024)
    Table 50. Schrodinger Recent Developments
    Table 51. In Silico Biosciences Basic Information List
    Table 52. In Silico Biosciences Description and Business Overview
    Table 53. In Silico Biosciences Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of In Silico Biosciences (2019-2024)
    Table 55. In Silico Biosciences Recent Developments
    Table 56. Genedata Basic Information List
    Table 57. Genedata Description and Business Overview
    Table 58. Genedata Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Genedata (2019-2024)
    Table 60. Genedata Recent Developments
    Table 61. Physiomics Basic Information List
    Table 62. Physiomics Description and Business Overview
    Table 63. Physiomics Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Physiomics (2019-2024)
    Table 65. Physiomics Recent Developments
    Table 66. Insilico Biotechology Basic Information List
    Table 67. Insilico Biotechology Description and Business Overview
    Table 68. Insilico Biotechology Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Insilico Biotechology (2019-2024)
    Table 70. Insilico Biotechology Recent Developments
    Table 71. Chemical Computing Group ULC(CCG) Basic Information List
    Table 72. Chemical Computing Group ULC(CCG) Description and Business Overview
    Table 73. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Chemical Computing Group ULC(CCG) (2019-2024)
    Table 75. Chemical Computing Group ULC(CCG) Recent Developments
    Table 76. Evidera Basic Information List
    Table 77. Evidera Description and Business Overview
    Table 78. Evidera Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Evidera (2019-2024)
    Table 80. Evidera Recent Developments
    Table 81. AnyLogic Basic Information List
    Table 82. AnyLogic Description and Business Overview
    Table 83. AnyLogic Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of AnyLogic (2019-2024)
    Table 85. AnyLogic Recent Developments
    Table 86. Shanghai Lide Basic Information List
    Table 87. Shanghai Lide Description and Business Overview
    Table 88. Shanghai Lide Personalized Therapy Biosimulation Platform Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Personalized Therapy Biosimulation Platform Business of Shanghai Lide (2019-2024)
    Table 90. Shanghai Lide Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Personalized Therapy Biosimulation Platform Downstream Customers
    Table 94. Personalized Therapy Biosimulation Platform Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Personalized Therapy Biosimulation Platform Product Picture
    Figure 2. Global Personalized Therapy Biosimulation Platform Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 4. Personalized Therapy Biosimulation Platform Report Years Considered
    Figure 5. Global Personalized Therapy Biosimulation Platform Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Personalized Therapy Biosimulation Platform Revenue in 2023
    Figure 7. Personalized Therapy Biosimulation Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Pharmacokinetic Picture
    Figure 9. Pharmacoeconomics Picture
    Figure 10. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Personalized Therapy Biosimulation Platform Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Pharmaceutical and Biotech Companies
    Figure 13. Product Picture of Research Institutions
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Others
    Figure 16. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Personalized Therapy Biosimulation Platform Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Personalized Therapy Biosimulation Platform Sales Value (%), (2019-2030)
    Figure 29. United States Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Personalized Therapy Biosimulation Platform Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Personalized Therapy Biosimulation Platform Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Personalized Therapy Biosimulation Platform Sales Value by Application (%), 2023 VS 2030
    Figure 50. Personalized Therapy Biosimulation Platform Industrial Chain
    Figure 51. Personalized Therapy Biosimulation Platform Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21S8513
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17L15214
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19V14797
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart